化工社化工社 化学情報印刷レポート · 研究参考用
HRID 230039作成日:2026年10月23日
N-Ethylpiperidine → (3s,4r)-3-[(1r)-1-(Tert-butyldimethylsilyloxy)ethyl]-4-[(1r)-1-methyl-2-[7-dimethoxymethyl(pyridin-3-yl)imidazo[5,1-b]thiazol-2-yl]-2-oxoethyl]azetidin-2-one
https://huagongshe.com/ja/reaction/230039
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | N-Ethylpiperidine | HCID 13007 | — |
| 反応物 | Sodium Bicarbonate | HCID 516892 | — |
| 反応物 | Tin(II) trifluoromethanesulfonate | HCID 2776843 | — |
| 反応物 | (3R,4R)-4-Acetoxy-3-((R)-(tert-butyldimethylsilyloxy)ethyl)-2-azetidinone | HCID 13073890 | — |
| 反応物 | 2-Propionyl-7-(pyridin-3-yl)dimethoxymethylimidazo[5,1-b]thiazole | HCID 68821100 | — |
| 溶媒 | Dichloromethane | HCID 6344 | — |
| 生成物 | (3s,4r)-3-[(1r)-1-(Tert-butyldimethylsilyloxy)ethyl]-4-[(1r)-1-methyl-2-[7-dimethoxymethyl(pyridin-3-yl)imidazo[5,1-b]thiazol-2-yl]-2-oxoethyl]azetidin-2-one | HCID 68821587 | — |
反応手順
Methylene chloride (2 ml) was added to 0.69 g of tin(II) trifluoromethanesulfonate under an argon atmosphere, and the mixture was cooled to −20° C. A solution of 0.25 g of 2-propionyl-7-(pyridin-3-yl)dimethoxymethylimidazo[5,1-b]thiazole in 1.5 ml of methylene chloride and 0.12 ml of N-ethylpiperidine were added thereto, and the mixture was stirred for 2 hr. A solution of 0.14 g of (3S,4R)-4-acetoxy-3-[(1R)-1-tert-butyldimethylsilyloxyethyl]azetidin-2-one in 1 ml of methylene chloride was added at 0° C., and the mixture was stirred at room temperature for one hr. A saturated aqueous sodium bicarbonate solution was added to the reaction mixture to stop the reaction, and the reaction mixture was extracted with ethyl acetate. The organic layer was washed with a 5% aqueous sodium bicarbonate solution and a 20% aqueous sodium chloride solution in that order and was dried over anhydrous magnesium sulfate. The solvent was removed by evaporation, and the residue was analyzed by HPLC (Cosmosil 5C18-MS, 4.6×150 mm, a 70% aqueous acetonitrile solution). As a result, it was found that the yield of (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(1R)-1-methyl-2-[7-dimethoxy(pyridin-3-yl)methylimidazo[5,1-b]thiazol-2-yl]-2-oxoethyl]azetidin-2-one was 45 mg. The results of analysis by NMR were in agreement with the results of analysis in Example 18.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07563901B2 |
|---|
| 出典データセット | uspto-grants-2009_07 |
|---|
| ORD ID | ord-c0f6e14cadd44475a35018cc9c527f1a |
|---|
| 出典メモ | uspto-grants-2009_07 |
|---|